Retsevmo (Selpercatinib Capsule) 40mg

RETSEVMO (selpercatinib) 40mg capsules are prescribed for targeted cancer therapy. This oral medication is used to treat specific types of thyroid and lung cancers. Store at room temperature, away from moisture and heat. Always follow healthcare provider instructions.

Strength

40mg

Pack Size

56s

Storage

Ambient

Manufacturer / TM Owner

LILLY DEUTSCHLAND Gmb

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Selpercatinib is a kinase inhibitor used in the treatment of certain cancers, including medullary thyroid cancer and non-small cell lung cancer. It targets specific genetic mutations to help control tumor growth. This medication is typically prescribed when cancer has spread or cannot be treated with surgery. Patients should discuss their specific diagnosis with a healthcare provider to determine suitability.

Side Effects

Common effects of selpercatinib may include mild nausea, fatigue, or headache. Some patients report dizziness or dry mouth during treatment. These effects are usually temporary and vary by individual. Regular monitoring by a healthcare provider helps manage any persistent or severe reactions.

Precautions & Warnings

Keep RETSEVMO capsules in their original container, tightly closed, and at room temperature. Avoid exposure to high humidity or direct sunlight. Do not crush, chew, or open capsules unless instructed by a healthcare professional. Inform your doctor about all medications and supplements you are taking before starting this treatment.

Avoid Interactions

Selpercatinib may interact with other medications, including certain antibiotics, antifungals, and heart medications. Avoid grapefruit products, as they can affect how the drug is processed in the body. Alcohol use should be discussed with a healthcare provider, as it may worsen side effects like dizziness. Always review your full medication list with a doctor or pharmacist.

Frequently Asked Questions

RETSEVMO (selpercatinib) is used to treat specific types of thyroid and lung cancers, particularly those with certain genetic mutations.

Store RETSEVMO capsules at room temperature, away from moisture and heat, in their original tightly closed container.

Consult your healthcare provider before combining RETSEVMO with other drugs, as interactions may occur.

Common side effects may include nausea, fatigue, headache, dizziness, or dry mouth. Report persistent effects to your doctor.

No, RETSEVMO is a prescription medication and requires a doctor's authorization for purchase.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.